astrazeneca (bank)

literal strings: Astrazeneca, AstraZeneca, astrazeneca, ASTRAZENECA

categories

NELL has only weak evidence for items listed in grey

• bank
• SEAL @637 (51.9%) on 19-sep-2012 [ 1 ] using astrazeneca

relations

NELL has only weak evidence for items listed in grey

• agentworkedondrug
• accolate
• SEAL @224 (93.8%) on 24-mar-2011 [ 1 2 3 4 ] using (accolate, astrazeneca)
• accupril
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (accupril, astrazeneca)
• anastrozole
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (anastrozole, astrazeneca)
• OE @892 (100.0%) on 26-dec-2014 [ http://en.wikipedia.org/wiki/Anastrozole http://en.wikipedia.org/wiki/Anastrozole  ] using (anastrozole, astrazeneca)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 and is made by arg2" ] using (anastrozole, astrazeneca)
• arimidex
• OE @803 (95.9%) on 13-jan-2014 [   ] using (arimidex, astrazeneca)
• SEAL @221 (100.0%) on 18-mar-2011 [ 1 2 ] using (arimidex, astrazeneca)
• avelox
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (avelox, astrazeneca)
• bricanyl
• SEAL @269 (100.0%) on 24-may-2011 [ 1 2 ] using (bricanyl, astrazeneca)
• budesonide
• OE @803 (100.0%) on 13-jan-2014 [   ] using (budesonide, astrazeneca)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (budesonide, astrazeneca)
• caprelsa
• SEAL @613 (100.0%) on 17-jul-2012 [ 1 2 ] using (caprelsa, astrazeneca)
• casodex
• SEAL @221 (98.4%) on 18-mar-2011 [ 1 2 3 4 5 6 ] using (casodex, astrazeneca)
• crestor
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg1 is marketed by arg2" "arg1 is being manufactured by arg2" "arg1 is manufactured by arg2" "arg1 was marketed by arg2" ] using (crestor, astrazeneca)
• SEAL @209 (87.5%) on 14-feb-2011 [ 1 2 3 ] using (crestor, astrazeneca)
• entocort
• SEAL @269 (100.0%) on 24-may-2011 [ 1 2 ] using (entocort, astrazeneca)
• esomeprazole
• OE @830 (91.2%) on 13-apr-2014 [   ] using (esomeprazole, astrazeneca)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (esomeprazole, astrazeneca)
• faslodex
• SEAL @213 (100.0%) on 21-feb-2011 [ 1 2 ] using (faslodex, astrazeneca)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 received FDA approval for arg1" ] using (faslodex, astrazeneca)
• iressa
• OE @830 (91.1%) on 13-apr-2014 [   ] using (iressa, astrazeneca)
• SEAL @213 (98.4%) on 21-feb-2011 [ 1 2 3 4 5 6 ] using (iressa, astrazeneca)
• metoprolol
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (metoprolol, astrazeneca)
• OE @823 (100.0%) on 17-mar-2014 [   ] using (metoprolol, astrazeneca)
• nexium
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 is being manufactured by arg2" "arg1 is marketed by arg2" ] using (nexium, astrazeneca)
• SEAL @209 (87.5%) on 14-feb-2011 [ 1 2 3 ] using (nexium, astrazeneca)
• nolvadex
• SEAL @269 (100.0%) on 24-may-2011 [ 1 2 ] using (nolvadex, astrazeneca)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 Plc under the brand arg1" "arg2 the clinician camps arg1" "arg2 in which they found that arg1" ] using (nolvadex, astrazeneca)
• prilosec
• OE @892 (100.0%) on 26-dec-2014 [ http://en.wikipedia.org/wiki/Omeprazole  ] using (prilosec, astrazeneca)
• SEAL @305 (87.5%) on 19-jun-2011 [ 1 2 3 ] using (prilosec, astrazeneca)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg1 is a gimmick that arg2" "arg1 is manufactured by arg2" "arg1 is a consultant for arg2" "arg1 was first marketed by arg2" ] using (prilosec, astrazeneca)
• relpax
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (relpax, astrazeneca)
• seloken
• SEAL @269 (100.0%) on 24-may-2011 [ 1 2 ] using (seloken, astrazeneca)
• seroquel
• SEAL @224 (100.0%) on 24-mar-2011 [ 1 2 ] using (seroquel, astrazeneca)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 Settlement from arg2" "arg1 is marketed by arg2" ] using (seroquel, astrazeneca)
• symbicort
• SEAL @213 (75.0%) on 21-feb-2011 [ 1 2 ] using (symbicort, astrazeneca)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 to make case for arg1" "arg2 under the trade name arg1" ] using (symbicort, astrazeneca)
• synthroid
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (synthroid, astrazeneca)
• tenormin
• SEAL @577 (100.0%) on 24-may-2012 [ 1 ] using (tenormin, astrazeneca)
• OE @1075 (100.0%) on 01-sep-2017 [ http://heart-disease.emedtv.com/tenormin/tenormin.html  ] using (tenormin, astrazeneca)
• toprol_xl
• SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (toprol_xl, astrazeneca)
• zestril
• SEAL @263 (100.0%) on 22-may-2011 [ 1 2 ] using (zestril, astrazeneca)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 with the brand name arg1" "arg2 manufactures arg1" ] using (zestril, astrazeneca)
• zoladex
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is marketed by arg2" ] using (zoladex, astrazeneca)
• SEAL @221 (93.8%) on 18-mar-2011 [ 1 2 3 4 ] using (zoladex, astrazeneca)
• cityhasstreet
• north
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 Carolina and arg2" ] using (north, astrazeneca)
• inverseofbankboughtbank
• chase
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 Chase and arg2" ] using (jp_morgan, astrazeneca)
• agentworkedondrug
• bydureon
• OE @949 (88.6%) on 20-sep-2015 [ http://www.fiercepharma.com/story/new-report-finds-bydureon-safest-new-class-diabetes-drugs/2014-04-16 http://www.fiercepharmamanufacturing.com/story/bristol-myers-astrazeneca-recall-92000-vials-bydureon-eu/2013-09-23 http://www.fiercepharmamarketing.com/story/lillys-dulaglutide-matches-victoza-study-real-loser-astrazenecas-bydureon/2014-02-26 http://www.fiercedrugdelivery.com/story/astrazeneca-looks-pen-injector-approval-turn-bydureon-diabetes-sales-around/2014-03-05 http://www.fiercepharmamarketing.com/story/lillys-dulaglutide-matches-victoza-study-real-loser-astrazenecas-bydureon/2014-02-26 http://www.astrazeneca-us.com/media/press-releases/Article/bydureon-pen-now-available-in-pharmacies http://www.fiercepharmamarketing.com/story/lillys-dulaglutide-matches-victoza-study-real-loser-astrazenecas-bydureon/2014-02-26 http://www.fiercedrugdelivery.com/story/astrazeneca-looks-pen-injector-approval-turn-bydureon-diabetes-sales-around/2014-03-05 http://www.bydureonhcp.com/ http://diatribe.org/issues/69/new-now-next/5 http://www.in-pharmatechnologist.com/Drug-Delivery/US-FDA-approves-AZ-s-Bydureon-Pen-as-Lilly-eyes-GLP-1-market  ] using (bydureon, astrazeneca)
• SEAL @878 (100.0%) on 10-oct-2014 [ 1 2 ] using (bydureon, astrazeneca)